Byheart Acquires Additional Domestic Infant Formula Manufacturing Facility Tripling Its Supply Capacity And Continuing To Fortify Formula Production In The U.S.
Byheart Acquires Additional Domestic Infant Formula Manufacturing Facility Tripling Its Supply Capacity And Continuing To Fortify Formula Production In The U.S.
01/25/23, 11:17 AM
Location
new yorkIndustry
manufacturing
health care
food and beverage
Today, ByHeart announces the acquisition of an additional manufacturing facility that will enable the next-generation baby nutrition company to scale production capacity of its breakthrough infant formula and increase domestic infant formula supply. Recognizing that the formula industry, which historically has been dominated by three players who control 90% of the market, was in need of change, ByHeart founders Ron Belldegrun and Mia Funt began working with DairiConcepts' FDA-registered facility in Allerton, Iowa, in 2018 to proactively build redundancy into their production ecosystem.
Company Info
Location
131 varick street
New York, New York, United States
Company info
ByHeart is an infant nutrition company built from the ground up to deliver real innovation on behalf of babies and parents. Our mission is simple: make the best formula in the world. That’s why we studied the latest breast milk science, worked directly with suppliers we know and trust, set uncompromising quality standards, developed our own small batch blending process, built our own manufacturing facilities, and conducted a groundbreaking clinical trial. Our goal is to create a future where all parents feel amazing about feeding their baby—no matter how they do it.